The Middle East Clinical Biomarkers Market is showing strong growth momentum, valued at USD 1.2 billion in 2024 and expected to reach USD 3.5 billion by 2034, growing at a compound annual growth rate (CAGR) of 11.5%. This steady expansion reflects the growing demand for better diagnostic tools, early disease detection, and more targeted treatment approaches across the region. One of...